Cardioversion and Risk of Adverse Events with Dabigatran versus Warfarin—A Nationwide Cohort Study

AIM: Cardioversion can rapidly and effectively restore sinus rhythm in patients with persistent atrial fibrillation. Since 2011 dabigatran has been available as an alternative to warfarin to prevent thromboembolic events in patients with non-valvular atrial fibrillation undergoing cardioversion. We...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:PLoS One
Prif Awduron: Pallisgaard, Jannik Langtved, Lindhardt, Tommi Bo, Hansen, Morten Lock, Schjerning, Anne-Marie, Olesen, Jonas Bjerring, Staerk, Laila, Torp-Pedersen, Christian, Gislason, Gunnar Hilmar
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Public Library of Science 2015
Pynciau:
Research Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC4625957/
https://ncbi.nlm.nih.gov/pubmed/26513589
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0141377
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg